Indian origin doc suggests Pb govt genome therapy for cancer

Image
Press Trust of India Chandigarh
Last Updated : Jul 17 2017 | 10:32 PM IST
An Indian origin doctor has suggested the Punjab government a new genome therapy for treatment of cancer patients in the state.
The suggestion was made by Manoj K Bhasin, an Assistant Professor of Medicine at Harvard Medical School in the US, at a meeting with Chief Minister Amarinder Singh here, an official release said.
Bhasin said the new therapy was based on sampling of genome taken from cancer patients and then characterise, store and sequence it to ascertain the nature and type of cancer.
The therapy could eventually prove to be quite effective in cancer treatment, he said.
Bhaisn also proposed collaboration between Harvard Medical School and the upcoming Tata Medical Centre at Medi City in Mullanpur, near New Chandigarh, for implementation of the genome therapy.
The Chief Minister assured him of all support by his government to take the venture forward and directed the chief secretary to convene a meeting with Bhasin to chalk out a comprehensive plan for its implementation.
Singh also asked the chief secretary to involve the state government Medical Colleges at Patiala, Faridkot and Amritsar, besides the Homi Bhabha Cancer Hospital at Sangrur and the Advanced Cancer Centre at Bathinda, for genome sampling.
Singh told the chief secretary the departments of Health and Medical Education, and Health & Family Welfare should be involved in the programme to combat cancer, which was wreaking havoc on the lives of people in Punjab, especially in the southern parts of the state.
The chief minister also gave in principle nod to Bhasin's proposal of initiating a meditation and yoga programme for the drug addicts as a pilot project, an official spokesperson said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 17 2017 | 10:32 PM IST

Next Story